通宇通訊(002792.SZ):持續看好光通信業務,依然是光為公司重要參股股東
格隆匯5月26日丨通宇通訊(002792.SZ)於2023年5月25日15:00-17:00接受機構調研、現場參觀,互動交流中,就“公司出售主營光模塊子公司是出於何種考慮,公司對光模塊未來發展是如何看待的呢?”,公司回覆稱,公司當初收購光為主要是考慮當時主業業績波動較大,希望切入光通信業務,實現產業和客户協同。今年出售深圳光為股權,主要是為引入國資股東,優化股東結構,促進光模塊業務更好發展。光模塊市場需求增長比天線業務需求增長要快,公司持續看好光通信業務,依然是光為公司重要參股股東,在銷售端長期協同。今年4月,公司中標中國電信光模塊集採項目,光通信業務發展良好。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.